Evolent Health, Inc. (EVH) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Evolent Health, Inc. (EVH) stock forecast summary
On Oct. 16, 2026, EVH is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
Evolent Health, Inc. is a small-cap company with a market capitalization of $517M. It ranks number 4 by market capitalization among the 5 Services-Management Services issuers in our coverage with a current forecast.
For EVH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 33.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 39.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, EVH included.
Follow EVH freeEVH price chart and AI forecast
How EVH ranks among 5172 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Evolent Health, Inc. (EVH) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Management Services peers listed below that report each metric.
Valuation & Market
| Metric | EVH | Rank |
|---|---|---|
| Market Cap | $517M | 4/5 |
| P/B Ratio | 0.60x | – |
| EPS | $-4.88 | – |
| Book Value/Share | $7.60 | – |
| Revenue/Share | $18.55 | – |
Profitability & Margins
| Metric | EVH | Rank |
|---|---|---|
| Gross Margin | 17.2% | – |
| Operating Margin | 18.2% | – |
| EBT Margin | 21.4% | – |
| Tax Rate | -0.6% | – |
Financial Health
| Metric | EVH | Rank |
|---|---|---|
| Current Ratio | 1.24x | 1/6 |
| D/E Ratio | 1.11x | – |
| Interest Coverage | -2.2x | 3/5 |
| Working Capital | $118M | 2/6 |
Cash Flow
| Metric | EVH | Rank |
|---|---|---|
| Operating Cash Flow | $54M | 2/5 |
Operational Efficiency
| Metric | EVH | Rank |
|---|---|---|
| Receivables Turnover | 4.7x | – |
| Fixed Assets Turnover | 25.6x | – |
| Days Sales Outstanding | 78 days | – |
| Payables Period | 8 days | – |
Income Statement
| Metric | EVH | Rank |
|---|---|---|
| Total Revenue | $2.10B | – |
| Operating Income | -$428M | 5/5 |
| SG&A Expense | $292M | – |
| Cost of Goods Sold | $1.74B | – |
Dividend & Shareholder Information
| Metric | EVH | Rank |
|---|---|---|
| Shares Outstanding | 113M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $611M | 33.6% of assets |
| Cash & Short-term Investments | $116M | 6.4% of assets |
| Accounts Receivable | $449M | 24.7% of assets |
| Total Liabilities | $958M | 52.7% of assets |
| Short-term Debt | $454M | 25.0% of assets |
EVH quarterly financials and insider trading
Evolent Health, Inc. (EVH) industry peers
Companies classified under the same SEC industry code as Evolent Health, Inc. (Services-Management Services): 6 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere EVH sits on the market map
Evolent Health, Inc. (EVH) stock news
Loading...
Evolent Health, Inc. (EVH) stock forecast FAQ
What is the Evolent Health, Inc. (EVH) stock forecast?
On Oct. 16, 2026, EVH is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
How accurate are Evolent Health, Inc. stock predictions?
For EVH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 33.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 39.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Evolent Health, Inc. forecasts updated?
Evolent Health, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Evolent Health, Inc.'s industry peers?
6 issuers in our coverage, EVH included, share the SEC industry code Services-Management Services. The largest are: Bryn Inc. (BRRN), Gartner Inc (IT), Rentokil Initial Plc /Fi (RTO), Franklin Covey Co (FC), Sky Century Investment, Inc. (SKYI).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.